Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-13-000033
Filing Date
2013-11-01
Accepted
2013-11-01 16:20:38
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arraybiopharmaq1f1410q.htm 10-Q 829934
2 DRUG DISCOVERY AND DEVELOPMENT OPTION AND LICENSE AGREEMENT exhibit102.htm EX-10.2 333104
3 SECTION 302 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER exhibit311q1f14.htm EX-31.1 14146
4 SECTION 302 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER exhibit312q1f14.htm EX-31.2 13442
5 SECTION 906 CERTIFICATIONS OF THE CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICERS exhibit321q1f14.htm EX-32.1 11659
  Complete submission text file 0001100412-13-000033.txt   5838064

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arry-20130930.xml EX-101.INS 737243
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20130930.xsd EX-101.SCH 39815
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20130930_cal.xml EX-101.CAL 58929
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20130930_def.xml EX-101.DEF 197619
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20130930_lab.xml EX-101.LAB 519843
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20130930_pre.xml EX-101.PRE 290360
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

EIN.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 131186137
SIC: 2834 Pharmaceutical Preparations